NanoBio Corporation to Report Data on its Nanoemulsion Adjuvanted Intranasal RSV Vaccine at the 8th Annual International Respiratory Syncytial Virus Symposium

Published: Sep 24, 2012

ANN ARBOR, Mich. & SANTA FE, N.M.--(BUSINESS WIRE)--NanoBio® Corporation announced today it will present data from three preclinical studies at the 8th Annual International Respiratory Syncytial Virus (RSV) Symposium taking place from Sept. 27-30 in Santa Fe, N.M.

Back to news